2023 Q2 Form 10-Q Financial Statement

#000182314423000011 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $98.53M $97.20M
YoY Change 1.37%
Cost Of Revenue $44.59M $38.35M
YoY Change 16.28% 38.94%
Gross Profit $53.94M $58.85M
YoY Change -8.35% 67.67%
Gross Profit Margin 54.74% 60.55%
Selling, General & Admin $23.59M $24.43M
YoY Change -3.46% 128.35%
% of Gross Profit 43.73% 41.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.131M $2.218M
YoY Change -3.92% -14.03%
% of Gross Profit 3.95% 3.77%
Operating Expenses $23.59M $24.43M
YoY Change -3.46% 1652.79%
Operating Profit $30.35M $34.42M
YoY Change -11.82% -2569.17%
Interest Expense -$5.442M -$5.358M
YoY Change 1.57% -73.56%
% of Operating Profit -17.93% -15.57%
Other Income/Expense, Net $3.331M $34.40M
YoY Change -90.32% -269.77%
Pretax Income $33.68M $63.46M
YoY Change -46.93% -393.04%
Income Tax $970.0K $2.802M
% Of Pretax Income 2.88% 4.42%
Net Earnings $5.737M $8.474M
YoY Change -32.3% -139.13%
Net Earnings / Revenue 5.82% 8.72%
Basic Earnings Per Share $0.31 $0.56
Diluted Earnings Per Share $0.29 $261.8K
COMMON SHARES
Basic Shares Outstanding 18.54M shares 15.05M shares
Diluted Shares Outstanding 35.53M shares 32.36M shares

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.61M $13.39M
YoY Change 68.87% 74088.37%
Cash & Equivalents $22.61M $13.39M
Short-Term Investments
Other Short-Term Assets $4.096M $3.740M
YoY Change 9.52% 1019.56%
Inventory $48.89M $28.74M
Prepaid Expenses
Receivables $36.53M $45.21M
Other Receivables $0.00 $0.00
Total Short-Term Assets $112.1M $91.08M
YoY Change 23.11% 25768.22%
LONG-TERM ASSETS
Property, Plant & Equipment $24.18M $30.40M
YoY Change -20.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $36.32M $30.38M
YoY Change 19.57%
Total Long-Term Assets $68.93M $60.78M
YoY Change 13.41% -74.28%
TOTAL ASSETS
Total Short-Term Assets $112.1M $91.08M
Total Long-Term Assets $68.93M $60.78M
Total Assets $181.1M $151.9M
YoY Change 19.23% -35.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.635M $6.857M
YoY Change -3.24% 210.07%
Accrued Expenses $10.77M $27.82M
YoY Change -61.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $18.75M $4.997M
YoY Change 275.23%
Total Short-Term Liabilities $50.85M $39.68M
YoY Change 28.17% 1662.24%
LONG-TERM LIABILITIES
Long-Term Debt $334.9M $376.9M
YoY Change -11.14%
Other Long-Term Liabilities $67.19M $70.38M
YoY Change -4.54% 54.63%
Total Long-Term Liabilities $402.1M $447.3M
YoY Change -10.1% 882.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $50.85M $39.68M
Total Long-Term Liabilities $402.1M $447.3M
Total Liabilities $453.0M $1.094B
YoY Change -58.59% 2189.8%
SHAREHOLDERS EQUITY
Retained Earnings -$906.5M -$964.9M
YoY Change -6.05% 1939.06%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$868.5M -$941.9M
YoY Change
Total Liabilities & Shareholders Equity $181.1M $151.9M
YoY Change 19.23% -35.83%

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $5.737M $8.474M
YoY Change -32.3% -139.13%
Depreciation, Depletion And Amortization $2.131M $2.218M
YoY Change -3.92% -14.03%
Cash From Operating Activities $28.08M $39.48M
YoY Change -28.87% -9150.11%
INVESTING ACTIVITIES
Capital Expenditures $2.031M -$2.087M
YoY Change -197.32% -315.15%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.031M -$2.087M
YoY Change -2.68% 115.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -26.00M -39.48M
YoY Change -34.13% -98805.0%
NET CHANGE
Cash From Operating Activities 28.08M 39.48M
Cash From Investing Activities -2.031M -2.087M
Cash From Financing Activities -26.00M -39.48M
Net Change In Cash 48.00K -2.087M
YoY Change -102.3% 426.67%
FREE CASH FLOW
Cash From Operating Activities $28.08M $39.48M
Capital Expenditures $2.031M -$2.087M
Free Cash Flow $26.05M $41.57M
YoY Change -37.33% -3056.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 cmpo Net Income Losses
NetIncomeLosses
2329000 usd
CY2023Q1 cmpo Net Income Losses Attributable To Redeemable Noncontrolling Interest
NetIncomeLossesAttributableToRedeemableNoncontrollingInterest
8408000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
146000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1649000 usd
CY2023Q1 cmpo Adjustments To Paid In Capital Tax Receivable Agreement Liability
AdjustmentsToPaidInCapitalTaxReceivableAgreementLiability
-290000 usd
CY2023Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
12055000 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
12055000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-887742000 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
596587000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
19294000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4393000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
243000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
74000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1276000 usd
CY2023Q2 cmpo Adjustments To Paid In Capital Tax Receivable Agreement Liability
AdjustmentsToPaidInCapitalTaxReceivableAgreementLiability
-1000 usd
CY2023Q2 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
26973000 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-26973000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-868489000 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
596587000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
726000 usd
CY2022Q1 cmpo Net Income Losses
NetIncomeLosses
3394000 usd
CY2022Q1 cmpo Net Income Losses Attributable To Redeemable Noncontrolling Interest
NetIncomeLossesAttributableToRedeemableNoncontrollingInterest
23514000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3869000 usd
CY2022Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
23514000 usd
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
23514000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-984904000 usd
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
608311000 usd
CY2022Q2 us-gaap Dividends
Dividends
25729000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3014000 usd
CY2022Q2 cmpo Net Income Losses
NetIncomeLosses
8474000 usd
CY2022Q2 cmpo Net Income Losses Attributable To Redeemable Noncontrolling Interest
NetIncomeLossesAttributableToRedeemableNoncontrollingInterest
52184000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1488000 usd
CY2022Q2 cmpo Adjustments To Paid In Capital Tax Receivable Agreement Liability
AdjustmentsToPaidInCapitalTaxReceivableAgreementLiability
2055000 usd
CY2022Q2 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
53677000 usd
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
53677000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-941924000 usd
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
606818000 usd
us-gaap Profit Loss
ProfitLoss
43447000 usd
us-gaap Profit Loss
ProfitLoss
87566000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4171000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4567000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8415000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4020000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
700000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1252000 usd
cmpo Derivative Instrument Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability
4221000 usd
cmpo Derivative Instrument Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability
19041000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
7968000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-18041000 usd
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-513000 usd
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-61000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1770000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3094000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-738000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17282000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6515000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2938000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
272000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1144000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-492000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-201000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
612000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10262000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-313000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-784000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
52981000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
51391000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5697000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3504000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5697000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3504000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
389000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10000000 usd
cmpo Payment On Tax Receivable Agreement Liability
PaymentOnTaxReceivableAgreementLiability
0 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
5017000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
16878000 usd
cmpo Payment Of Distributions To Noncontrolling Interests
PaymentOfDistributionsToNoncontrollingInterests
29008000 usd
cmpo Payment Of Distributions To Noncontrolling Interests
PaymentOfDistributionsToNoncontrollingInterests
25729000 usd
cmpo Payment Of Issuance Costs Recapitalization
PaymentOfIssuanceCostsRecapitalization
0 usd
cmpo Payment Of Issuance Costs Recapitalization
PaymentOfIssuanceCostsRecapitalization
23833000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38312000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-56440000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8972000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8553000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13642000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21944000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22614000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13391000 usd
us-gaap Interest Paid Net
InterestPaidNet
13626000 usd
us-gaap Interest Paid Net
InterestPaidNet
9638000 usd
cmpo Noncash Change In Derivative Asset
NoncashChangeInDerivativeAsset
8329000 usd
cmpo Noncash Change In Derivative Asset
NoncashChangeInDerivativeAsset
5590000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain reclassifications have been made to conform to the current year presentation.
us-gaap Use Of Estimates
UseOfEstimates
The preparation of the consolidated financial statements requires management to make a number of estimates and assumptions relating to the reported amount of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. The Company bases its estimates on historical experience, current business factors and various other assumptions believed to be reasonable under the circumstances, all of which are necessary in order to form a basis for determining the carrying values of assets and liabilities. Actual results may differ from those estimates and assumptions. The Company evaluates the adequacy of its reserves and the estimates used in calculations on an on-going basis. Significant areas requiring management to make estimates include the valuation of equity instruments, measurement of changes in the fair value of earnout consideration liability, estimates of derivative liability associated with the Exchangeable Notes, which are marked to market each quarter based on a Lattice model approach, derivative asset for the interest rate swap, changes in the fair value of warrant liabilities, valuation allowances on deferred tax assets which are based on an assessment of recoverability of the deferred tax assets against future taxable income and estimates of the inputs used to calculate the tax receivable agreement liability.
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
cmpo Revenue Performance Obligation Payment Terms Minimum
RevenuePerformanceObligationPaymentTermsMinimum
P15D
cmpo Revenue Performance Obligation Payment Terms Maximum
RevenuePerformanceObligationPaymentTermsMaximum
P60D
cmpo Revenue Performance Obligation Payment Due
RevenuePerformanceObligationPaymentDue
P90D
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
46461000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
43313000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
4823000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2892000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
498000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
450000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2893000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4281000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
48889000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
42374000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
91563000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
85866000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
67381000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
63211000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24182000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22655000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2131000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2218000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4171000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4567000 usd
CY2023Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
798000 usd
CY2022Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
285000 usd
CY2023Q2 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
195000 usd
CY2022Q2 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
187000 usd
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-513000 usd
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-61000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
358105000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
363122000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
18750000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
14372000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
4426000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
5126000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
334929000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
343624000 usd
CY2023Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
798000 usd
CY2022Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
285000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
9355000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
18750000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
200000000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
130000000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
358105000 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
400000 usd
CY2023Q2 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
125000000 usd
CY2020Q4 us-gaap Derivative Assets
DerivativeAssets
0 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
8329000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
8651000 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4393000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3014000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8415000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4020000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4765545 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1440
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M18D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16939000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
958015 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
60.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6333000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3807530 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1770
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
19372000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3807530 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1770
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
19372000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3761909 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1720
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
19349000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
38214000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
cmpo Defined Contribution Plan Requisite Service Period
DefinedContributionPlanRequisiteServicePeriod
P90D
CY2023Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
396000 usd
CY2022Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
409000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
921000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
837000 usd
cmpo Deferred Compensation Arrangement With Individual Percent Of Ebitda Contributed
DeferredCompensationArrangementWithIndividualPercentOfEBITDAContributed
0.0025
CY2023Q2 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
0 usd
CY2022Q4 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
242000 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
8329000 usd
CY2023Q2 cmpo Derivative Instrument Contingent Consideration Liability
DerivativeInstrumentContingentConsiderationLiability
10869000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
798000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
8651000 usd
CY2022Q4 cmpo Derivative Instrument Contingent Consideration Liability
DerivativeInstrumentContingentConsiderationLiability
15090000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
285000 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
16341000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
7968000 usd
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
24309000 usd
CY2023Q2 us-gaap Share Price
SharePrice
6.86
CY2023Q2 cmpo Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
7500000 shares
CY2022Q4 cmpo Derivative Instrument Contingent Consideration Liability
DerivativeInstrumentContingentConsiderationLiability
15090000 usd
cmpo Derivative Instrument Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability
4221000 usd
CY2023Q2 cmpo Derivative Instrument Contingent Consideration Liability
DerivativeInstrumentContingentConsiderationLiability
10869000 usd
CY2023Q2 us-gaap Share Price
SharePrice
6.86
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98527000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97199000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
193843000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
181382000 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
970000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2802000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-293000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3345000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1265
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0442
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0068
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0368
CY2023Q2 us-gaap Profit Loss
ProfitLoss
32710000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
60658000 usd
us-gaap Profit Loss
ProfitLoss
43447000 usd
us-gaap Profit Loss
ProfitLoss
87566000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
26973000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
52184000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
35347000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
75628000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5737000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8474000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8100000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11938000 usd
CY2023Q2 us-gaap Dilutive Securities
DilutiveSecurities
4410000 usd
CY2022Q2 us-gaap Dilutive Securities
DilutiveSecurities
8236000 usd
us-gaap Dilutive Securities
DilutiveSecurities
6140000 usd
us-gaap Dilutive Securities
DilutiveSecurities
12267000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10147000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16710000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
14240000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
24205000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18537268 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15051732 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18087260 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14992612 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
16991161 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
17311560 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
17068029 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
17348682 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35528429 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32363292 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35155289 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32341294 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5737000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18537268 shares
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10147000 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35528429 shares
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8474000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15051732 shares
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16710000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8100000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18087260 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
14240000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35155289 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11938000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14992612 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
24205000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32341294 shares
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1116000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2245000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2319000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1882000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
912000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1205000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9679000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
530000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9149000 usd
CY2023Q2 cmpo Tax Receivable Agreement Liability To Be Paid Remainder Of Fiscal Year
TaxReceivableAgreementLiabilityToBePaidRemainderOfFiscalYear
174000 usd
CY2023Q2 cmpo Tax Receivable Agreement Liability To Be Paid Year One
TaxReceivableAgreementLiabilityToBePaidYearOne
1494000 usd
CY2023Q2 cmpo Tax Receivable Agreement Liability To Be Paid Year Two
TaxReceivableAgreementLiabilityToBePaidYearTwo
1484000 usd
CY2023Q2 cmpo Tax Receivable Agreement Liability To Be Paid Year Three
TaxReceivableAgreementLiabilityToBePaidYearThree
1513000 usd
CY2023Q2 cmpo Tax Receivable Agreement Liability To Be Paid Year Four
TaxReceivableAgreementLiabilityToBePaidYearFour
1544000 usd
CY2023Q2 cmpo Tax Receivable Agreement Liability To Be Paid After Year Four
TaxReceivableAgreementLiabilityToBePaidAfterYearFour
19411000 usd
CY2023Q2 cmpo Tax Receivable Agreement Liability
TaxReceivableAgreementLiability
25620000 usd
CY2023Q2 us-gaap Related Party Tax Expense Due From Affiliates Current
RelatedPartyTaxExpenseDueFromAffiliatesCurrent
25241000 usd
us-gaap Related Party Tax Expense Due From Affiliates Current
RelatedPartyTaxExpenseDueFromAffiliatesCurrent
37600000 usd

Files In Submission

Name View Source Status
0001823144-23-000011-index-headers.html Edgar Link pending
0001823144-23-000011-index.html Edgar Link pending
0001823144-23-000011.txt Edgar Link pending
0001823144-23-000011-xbrl.zip Edgar Link pending
cmpo-20230630.htm Edgar Link pending
cmpo-20230630.xsd Edgar Link pending
exhibit311q22023.htm Edgar Link pending
exhibit312q22023.htm Edgar Link pending
exhibit321q22023.htm Edgar Link pending
exhibit322q22023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
cmpo-20230630_cal.xml Edgar Link unprocessable
cmpo-20230630_pre.xml Edgar Link unprocessable
cmpo-20230630_def.xml Edgar Link unprocessable
cmpo-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cmpo-20230630_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending